Pet Cancer Therapeutics Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Combination Therapy), By Pet Type (Dog, Cat and Others), By Mode of Administration (Oral, Topical, Intravenous), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer and Others) and By Region - Trends, Analysis and Forecast till 2034

Based on geographic factors, the target market has been divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Because of the rising incidence and frequency of pet cancer cases, the increasing number of pet cancer drug approvals in this area, and the rising costs associated with research and development (R&D), North America is predicted to lead the pet cancer therapeutics market.